Joichi Kumazawa
- Surgery top 10%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 5%
- Urology top 1%
- Epidemiology top 10%
- Co-authors
- Tetsuro MatsumotoSeiji NaitoMasatoshi TanakaShuji KotohNaotaka SakamotoKoichi TakahashiJiro UozumiMasashi Haraoka
- Topics
- Urinary Tract Infections Management (37 papers)Urinary Bladder and Prostate Research (31 papers)Bladder and Urothelial Cancer Treatments (26 papers)
- Cited by
- UrologyMicrobiologyOncology
- Partner nations
- JapanUnited StatesBelgium
In The Last Decade
Joichi Kumazawa
169 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 119
- Surgery 531
- Molecular Biology 479
- Pulmonary and Respiratory Medicine 455
- Urology 431
- Epidemiology 417
Countries citing papers authored by Joichi Kumazawa
This map shows the geographic impact of Joichi Kumazawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joichi Kumazawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joichi Kumazawa more than expected).
Fields of papers citing papers by Joichi Kumazawa
This network shows the impact of papers produced by Joichi Kumazawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joichi Kumazawa. The network helps show where Joichi Kumazawa may publish in the future.
Co-authorship network of co-authors of Joichi Kumazawa
This figure shows the co-authorship network connecting the top 25 collaborators of Joichi Kumazawa. A scholar is included among the top collaborators of Joichi Kumazawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joichi Kumazawa. Joichi Kumazawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | The expression of drug-resistant genes and the acquirement of drug resistance in human bladder cancer cell lines | 1 |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 22 | |
| 7 | 1 | |
| 8 | Clinical study of tosufloxacin tosilate in the treatment of non-gonococcal urethritis | 5 |
| 9 | Intra-arterial chemotherapy for the treatment of invasive bladder cancer | 1 |
| 10 | Comparative study on levofloxacin and ofloxacin in complicated urinary tract infections | 5 |
| 11 | 4 | |
| 12 | 28 | |
| 13 | 9 | |
| 14 | 4 | |
| 15 | Multilocular cystic renal cell carcinoma: A case report | 1 |
| 16 | 7 | |
| 17 | Chronological changes of bacteria isolated from urinary tract infections (report XIII) | 1 |
| 18 | Clinical Experience With Cefixime In Urinary Tract Infections | 1 |
| 19 | Clinical evaluation of BRL25000 (clavulanic acid-amoxicillin) on urinary tract infections | 1 |
| 20 | Clinical effectiveness of lividomycin on urinary tract infections: evaluation with double-blind method. | 1 |
About Joichi Kumazawa
Joichi Kumazawa is a scholar working on Urology, Microbiology and Epidemiology, having authored 174 papers that have together received 2.2k indexed citations. Recurring topics across this work include Urinary Tract Infections Management (37 papers), Urinary Bladder and Prostate Research (31 papers) and Bladder and Urothelial Cancer Treatments (26 papers). The work is most often cited by research in Urology (431 citations), Microbiology (269 citations) and Oncology (391 citations). Joichi Kumazawa has collaborated with scholars based in Japan, United States and Belgium. Frequent co-authors include Tetsuro Matsumoto, Seiji Naito, Masatoshi Tanaka, Shuji Kotoh, Naotaka Sakamoto, Koichi Takahashi, Jiro Uozumi, Masashi Haraoka, Yoshimitsu Mizunoe and Masao Tanaka. Their work appears in journals such as Cancer, Clinical Infectious Diseases and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.